Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) EBITDA Margin (2016 - 2025)

INVO Fertility (IVF) has disclosed EBITDA Margin for 15 consecutive years, with 814.06% as the latest value for Q3 2025.

  • On a quarterly basis, EBITDA Margin rose 93710.0% to 814.06% in Q3 2025 year-over-year; TTM through Sep 2025 was 42.53%, a 6285.0% increase, with the full-year FY2024 number at 27.68%, up 19370.0% from a year prior.
  • EBITDA Margin was 814.06% for Q3 2025 at INVO Fertility, up from 158.76% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 814.06% in Q3 2025 to a low of 1825.62% in Q2 2022.
  • A 5-year average of 511.27% and a median of 227.51% in 2021 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -142904bps in 2022, then surged 117787bps in 2023.
  • INVO Fertility's EBITDA Margin stood at 16.89% in 2021, then plummeted by -5843bps to 970.3% in 2022, then soared by 89bps to 107.65% in 2023, then skyrocketed by 253bps to 164.81% in 2024, then soared by 394bps to 814.06% in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBITDA Margin are 814.06% (Q3 2025), 158.76% (Q2 2025), and 1043.09% (Q1 2025).